AR Tool for Post-Surgery Symptoms in Pediatric Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether an augmented reality (AR) tool can help track pain, nausea, and vomiting in children who have undergone cancer surgery. Participants will use a device that combines real-world views with digital images to determine if it aids in reporting their symptoms. The trial includes children aged 7 to 17 who have cancer or a benign tumor, are undergoing surgery lasting over two hours, and can understand English or Spanish. As an unphased trial, this study provides a unique opportunity to explore innovative technology that could enhance symptom tracking and management.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this augmented reality tool is safe for pediatric cancer patients?
Research has shown that virtual reality (VR), similar to augmented reality (AR), is usually safe for children. Studies found that side effects were rare and typically resolved on their own. VR and AR use devices to add digital images to the real world, making them fun and engaging for kids.
In medical settings, these technologies have shown promise. They help children feel more in control and can make medical experiences less stressful. With the right equipment and careful patient selection, AR is considered low-risk and well-tolerated. This makes it a promising option for helping kids after surgery, especially in managing symptoms like pain or nausea.
In summary, AR is generally safe for children and can be a helpful tool in medical care.12345Why are researchers excited about this trial?
Researchers are excited about using augmented reality (AR) for managing post-surgery symptoms in pediatric cancer patients because it represents a new way to engage young patients in their recovery. Unlike traditional methods that might involve medications for pain management or physical therapies, AR creates an immersive experience where digital characters and items interact with the real world through a screen. This approach not only makes the healing process more engaging for children but may also reduce anxiety and improve adherence to rehabilitation activities. By integrating fun and familiarity into their recovery, AR has the potential to enhance both mental and physical well-being in a way that traditional treatments might not.
What evidence suggests that this AR tool is effective for post-surgery symptoms in pediatric cancer patients?
Research has shown that augmented reality (AR), which participants in this trial will experience, can help manage pain and anxiety in children. Studies have found that hospitals can use AR to reduce pain and the need for pain medicine after surgery. Patients and caregivers have reported high satisfaction with AR, with most recommending its use. Although more research is needed to confirm these benefits, early results are promising for enhancing children's comfort and emotional well-being after surgery.56789
Who Is on the Research Team?
Juan Cata, MD
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for English or Spanish-speaking kids aged 7-17 with cancer who are having surgery lasting over 2 hours and will need painkillers like opioids after. They must be able to understand and use the game in the study, and have a guardian's consent. Kids can't join if their doctor thinks the app isn't right for them or if parents don't agree.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use an AR-based electronic tool to assess postoperative pain, nausea, and vomiting
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Augmented reality (AR)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Institute of Drug Abuse
Collaborator